Sun Life Financial Inc Lantheus Holdings, Inc. Transaction History

Sun Life Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$18.47 - $24.03 $181,744 - $236,455	-9,840 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$21.01 - $28.94 $1,176 - $1,620	56 Added 0.57%	9,840 $247,000
Q1 2019 May 14, 2019	BUY	$14.93 - $25.1 $791 - $1,330	53 Added 0.54%	9,784 $240,000
Q4 2018 Feb 06, 2019	BUY	$12.68 - $19.01 $621 - $931	49 Added 0.51%	9,731 $152,000
Q3 2018 Nov 13, 2018	BUY	$13.1 - $16.35 $786 - $981	60 Added 0.62%	9,682 $145,000
Q2 2018 Aug 09, 2018	BUY	$13.65 - $18.7 $131,340 - $179,931	9,622 New	9,622 $140,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Sun Life Financial Inc with notifications on news.